LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 33.32 | 84.90 | 2900 | 2722 | 1.0652 | 1.0254 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 35.03 | 84.90 | 2186 | 2991 | 0.7308 | 0.8816 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 35.03 | 84.90 | 2364 | 2991 | 0.7903 | 0.9105 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 35.03 | 84.90 | 2817 | 2991 | 0.9417 | 0.9768 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 35.03 | 84.90 | 3130 | 2991 | 1.0464 | 1.0177 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 36.73 | 84.90 | 2234 | 3254 | 0.6865 | 0.8620 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 36.73 | 84.90 | 2544 | 3254 | 0.7817 | 0.9085 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 36.73 | 84.90 | 3114 | 3254 | 0.9569 | 0.9833 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 36.73 | 84.90 | 3330 | 3254 | 1.0233 | 1.0088 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 38.43 | 84.90 | 2198 | 3459 | 0.6353 | 0.8374 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 38.43 | 84.90 | 2681 | 3459 | 0.7749 | 0.9069 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 38.43 | 84.90 | 3073 | 3459 | 0.8882 | 0.9562 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 38.43 | 84.90 | 3522 | 3459 | 1.0180 | 1.0067 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 40.14 | 84.90 | 2291 | 3682 | 0.6222 | 0.8329 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 40.14 | 84.90 | 2847 | 3682 | 0.7732 | 0.9076 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 40.14 | 84.90 | 3065 | 3682 | 0.8324 | 0.9337 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 40.14 | 84.90 | 3739 | 3682 | 1.0155 | 1.0057 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 41.84 | 84.90 | 2264 | 4003 | 0.5656 | 0.8051 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 41.84 | 84.90 | 2998 | 4003 | 0.7489 | 0.8986 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 41.84 | 84.90 | 2996 | 4003 | 0.7484 | 0.8984 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 41.84 | 84.90 | 3994 | 4003 | 0.9977 | 0.9992 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 43.55 | 84.90 | 2398 | 4287 | 0.5592 | 0.8048 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 43.55 | 84.90 | 3212 | 4287 | 0.7491 | 0.9005 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 43.55 | 84.90 | 3002 | 4287 | 0.7001 | 0.8779 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 43.55 | 84.90 | 4240 | 4287 | 0.9888 | 0.9960 | MN20160318_Q02 | I11 |